{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:19:16Z","timestamp":1790875156004,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2001,10,22]],"date-time":"2001-10-22T00:00:00Z","timestamp":1003708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,10,22]],"date-time":"2001-10-22T00:00:00Z","timestamp":1003708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.1038\/ni720","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:33:27Z","timestamp":1027672407000},"page":"1061-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":251,"title":["Development of chronic colitis is dependent on the cytokine MIF"],"prefix":"10.1038","volume":"2","author":[{"given":"Ype P.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Abadia-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend T.","family":"Rietdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen Al","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"ten Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Keates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi B.","family":"Lubetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Michetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander J.","family":"van Deventer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Lolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul K.","family":"Bhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cox","family":"Terhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,10,22]]},"reference":[{"key":"BFni720_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0065-2776(08)60598-2","volume":"66","author":"CN Metz","year":"1997","unstructured":"Metz, C. N. & Bucala, R. Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv. Immunol. 66, 197\u2013223 (1997).","journal-title":"Adv. Immunol."},{"key":"BFni720_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1357-4310(97)01133-7","volume":"3","author":"SC Donnelly","year":"1997","unstructured":"Donnelly, S. C. & Bucala, R. Macrophage migration inhibitory factor: a regulator of glucocoritcoid activity with a critical role in inflammatory disease. Mol. Med. Today 3, 502\u2013507 (1997).","journal-title":"Mol. Med. Today"},{"key":"BFni720_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/377068a0","volume":"377","author":"T Calandra","year":"1995","unstructured":"Calandra, T. et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68\u201371 (1995).","journal-title":"Nature"},{"key":"BFni720_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","volume":"179","author":"T Calandra","year":"1994","unstructured":"Calandra, T., Bernhagen, J., Mitchell, R. A. & Bucala, R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895\u20131902 (1994).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1084\/jem.189.2.341","volume":"189","author":"M Bozza","year":"1999","unstructured":"Bozza, M. et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341\u2013346 (1999).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/365756a0","volume":"365","author":"J Bernhagen","year":"1993","unstructured":"Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756\u2013759 (1993).","journal-title":"Nature"},{"key":"BFni720_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm0397-320","volume":"3","author":"SC Donnelly","year":"1997","unstructured":"Donnelly, S. C. et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nature Med. 3, 320\u2013323 (1997).","journal-title":"Nature Med."},{"key":"BFni720_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08830180009048387","volume":"19","author":"SJ Simpson","year":"2000","unstructured":"Simpson, S. J., de Jong, Y. P., Comiskey, M. & Terhorst, C. Pathways of T cell pathology in models of chronic intestinal inflammation. Int. Rev. Immunol. 19, 1\u201337 (2000).","journal-title":"Int. Rev. Immunol."},{"key":"BFni720_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","volume":"51","author":"KA Papadakis","year":"2000","unstructured":"Papadakis, K. A. & Targan, S. R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51, 289\u2013298 (2000).","journal-title":"Annu. Rev. Med."},{"key":"BFni720_CR10","first-page":"823","volume":"150","author":"P Parronchi","year":"1997","unstructured":"Parronchi, P. et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150, 823\u2013832 (1997).","journal-title":"Am. J. Pathol."},{"key":"BFni720_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1084\/jem.187.8.1225","volume":"187","author":"SJ Simpson","year":"1998","unstructured":"Simpson, S. J. et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12\/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon \u03b3 expression by T cells. J. Exp. Med. 187, 1225\u20131234 (1998).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR12","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.161.6.3143","volume":"161","author":"N Davidson","year":"1998","unstructured":"Davidson, N. J. et al. IL-12, but not IFN-\u03b3, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161, 3143\u20133149 (1998).","journal-title":"J. Immunol."},{"key":"BFni720_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/1074-7613(94)90045-0","volume":"1","author":"F Powrie","year":"1994","unstructured":"Powrie, F. et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553\u2013562 (1994).","journal-title":"Immunity"},{"key":"BFni720_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/S0016-5085(98)70025-3","volume":"115","author":"F Mackay","year":"1998","unstructured":"Mackay, F. et al. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 115, 1464\u20131475 (1998).","journal-title":"Gastroenterology"},{"key":"BFni720_CR15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.190.10.1479","volume":"190","author":"N Corazza","year":"1999","unstructured":"Corazza, N., Eichenberger, S., Eugster, H. P. & Mueller, C. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene RAG2\u2212\/\u2212 mice upon transfer of CD4+CD45RBhi T cells. J. Exp. Med. 190, 1479\u20131492 (1999).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/75068","volume":"6","author":"R Atreya","year":"2000","unstructured":"Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nature Med. 6, 583\u2013588 (2000).","journal-title":"Nature Med."},{"key":"BFni720_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1084\/jem.183.2.693","volume":"183","author":"E Stuber","year":"1996","unstructured":"Stuber, E., Strober, W. & Neurath, M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183, 693\u2013698 (1996).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/gast.2000.16485","volume":"119","author":"YP De Jong","year":"2000","unstructured":"De Jong, Y. P. et al. Chronic murine colitis is dependent on the CD154\/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 119, 715\u2013723 (2000).","journal-title":"Gastroenterology"},{"key":"BFni720_CR19","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.4049\/jimmunol.164.11.6005","volume":"164","author":"Z Liu","year":"2000","unstructured":"Liu, Z. et al. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. J. Immunol. 164, 6005\u20136014 (2000).","journal-title":"J. Immunol."},{"key":"BFni720_CR20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4049\/jimmunol.162.1.486","volume":"162","author":"LM Higgins","year":"1999","unstructured":"Higgins, L. M. et al. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162, 486\u2013493 (1999).","journal-title":"J. Immunol."},{"key":"BFni720_CR21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1084\/jem.187.6.855","volume":"187","author":"Y Cong","year":"1998","unstructured":"Cong, Y. et al. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H\/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187, 855\u2013864 (1998).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1053\/gast.2001.22547","volume":"120","author":"C Veltkamp","year":"2001","unstructured":"Veltkamp, C. et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in tg\u025b26 mice. Gastroenterology 120, 900\u2013913 (2001).","journal-title":"Gastroenterology"},{"key":"BFni720_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.179.2.589","volume":"179","author":"F Powrie","year":"1994","unstructured":"Powrie, F., Correa-Oliveira, R., Mauze, S. & Coffman, R. L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell- mediated immunity. J. Exp. Med. 179, 589\u2013600 (1994).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1053\/gast.2000.18164","volume":"119","author":"AC Keates","year":"2000","unstructured":"Keates, A. C. et al. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology 119, 972\u2013982 (2000).","journal-title":"Gastroenterology"},{"key":"BFni720_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1155\/1999\/506915","volume":"13","author":"EM Yoshida","year":"1999","unstructured":"Yoshida, E. M. The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn's disease. Can. J. Gastroenterol. 13, 65\u201373 (1999).","journal-title":"Can. J. Gastroenterol."},{"key":"BFni720_CR26","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan, S. R. et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn's disease. Crohn's Disease cA2 Study Group. N. Engl. J. Med. 337, 1029\u20131035 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFni720_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.153.3731.80","volume":"153","author":"BR Bloom","year":"1966","unstructured":"Bloom, B. R. & Bennett, B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80\u201382 (1966).","journal-title":"Science"},{"key":"BFni720_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1073\/pnas.56.1.72","volume":"56","author":"JR David","year":"1966","unstructured":"David, J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl Acad. Sci. USA 56, 72\u201377 (1966).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni720_CR29","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.1073\/pnas.95.19.11383","volume":"95","author":"T Calandra","year":"1998","unstructured":"Calandra, T., Spiegel, L. A., Metz, C. N. & Bucala, R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl Acad. Sci. USA 95, 11383\u201311388 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFni720_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","volume":"182","author":"MF Neurath","year":"1995","unstructured":"Neurath, M. F., Fuss, I., Kelsall, B. L., Stuber, E. & Strober, W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1281\u20131290 (1995).","journal-title":"J. Exp. Med."},{"key":"BFni720_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/72262","volume":"6","author":"T Calandra","year":"2000","unstructured":"Calandra, T. et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Med. 6, 164\u2013170 (2000).","journal-title":"Nature Med."},{"key":"BFni720_CR32","doi-asserted-by":"publisher","first-page":"7346","DOI":"10.1021\/bi990306m","volume":"38","author":"JB Lubetsky","year":"1999","unstructured":"Lubetsky, J. B., Swope, M., Dealwis, C., Blake, P. & Lolis, E. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 38, 7346\u20137354 (1999).","journal-title":"Biochemistry"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:50:02Z","timestamp":1684450202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["BFni720"],"URL":"https:\/\/doi.org\/10.1038\/ni720","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10,22]]},"assertion":[{"value":"5 April 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}